Grant-Huerta Yanina

Grant-Huerta Yanina is listed in filings as Chief Accounting Officer at Atara Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through May 20, 2026, including sale activity. Recent filings connect the profile to Atara Biotherapeutics, Inc. (ATRA). The current snapshot covers public activity from May 20, 2025 to May 20, 2026. Reported amounts are shown as $22.0K to $508. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.